Institutional members access full text with Ovid®

Share this article on:

Peptic ulcer disease

Louw, Japie A

Current Opinion in Gastroenterology: November 2006 - Volume 22 - Issue 6 - p 607–611
doi: 10.1097/01.mog.0000245532.12648.aa
Stomach and duodenum

Purpose of review This review attempts to contextualize some of the clinically important publications of the last 2 years as they relate to the broad topic of dyspepsia and peptic ulcer disease, both Helicobacter pylori and nonsteroidal anti-inflammatory drug-related.

Recent findings This review includes findings which provide insight with regard to the triaging of dyspeptic subjects, information on new proton pump inhibitor drugs and H. pylori eradication ‘rescue regimens’. The ‘COX-2 debacle’ is discussed and new data relating to the efficacy of co-therapy strategies for the prevention of nonsteroidal anti-inflammatory drug gastropathy are presented, while the use of antiplatelet agents as ‘safe’ substitutes for aspirin cardioprophylaxis is questioned. The important issue of proton pump inhibitor safety and nonsteroidal anti-inflammatory drug enteropathy are addressed.

Summary The review provides a summary and interpretation of literature pertaining to the above issues, and should provide a point of departure for clinical decision-making relevant to these issues.

Division of Gastroenterology, Queen's University/Hotel Dieu Hospital, Kingston, Ontario, Canada

Correspondence to J. A. Louw, MBChB, MMed, FCP(SA), PhD, FRCPC, Division of Gastroenterology, Queen's University/Hotel Dieu Hospital, Kingston, ON, Canada E-mail: louwj@hdh.kari.net

© 2006 Lippincott Williams & Wilkins, Inc.